Search results
J&J (JNJ) Seeks Expanded Use of Tremfya for Crohn's Disease
Zacks via Yahoo Finance· 19 hours agoJ&J (JNJ) seeks label expansion for Tremfya for treating moderately to severely active Crohn's...
Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio
Zacks via Yahoo Finance· 19 hours agoARQT is focused on developing and commercializing treatments for unmet needs in immune-mediated...
Yale dermatologist points to link between skin con | Newswise
Newswise· 2 days agoDr. Jeffrey Cohen, Assistant Professor and Director of the Psoriasis Treatment Program at Yale...
AbbVie (NYSE:ABBV) Stock Rating Reaffirmed by Cantor Fitzgerald
ETF DAILY NEWS· 5 hours agoAbbVie (NYSE:ABBV – Get Free Report)‘s stock had its “overweight” rating reissued by Cantor Fitzgerald in a note issued to investors on Thursday, Benzinga reports. Cantor Fitzgerald’s price ...
Nektar Therapeutics (NASDAQ:NKTR) Share Price Crosses Above Two Hundred Day Moving Average of $0.98
ETF DAILY NEWS· 5 hours agoNektar Therapeutics (NASDAQ:NKTR – Get Free Report) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.98 and traded as high ...
Psoriatic Arthritis Drugs Comparably Improve Joint Outcomes
Medscape· 3 days agoReal-world study data suggest there is little difference among five drug classes commonly used to...
Barstool's Dave Portnoy had basal cell carcinoma removed. Experts explain the skin cancer's risks,...
Yahoo Life Style via AOL· 1 day agoBCCs can also itch, ooze, bleed or scab over. In some cases they may grow over time. Skin Cancer...
Cryogenic chambers and infrared capsules. This ‘fitness hotel’ is taking wellness tech to the next...
CNN.com· 1 day agoEditor’s Note: This CNN series is, or was, sponsored by the country it highlights. There are...
Johnson & Johnson submits application to U.S. FDA seeking approval of TREMFYA® (guselkumab) for the...
The Woonsocket Call· 1 day agoJohnson & Johnson (NYSE: JNJ) today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of TREMFYA ...
States struggle to help patients navigate insurance hurdle known as ‘step therapy’
Missouri Independent via Yahoo News· 5 days agoCassidy Yermal, 32, began experiencing debilitating migraines when she was 17 years old. As a...